Engitix and Dompé collaboration for fibrosis and cancer AI drug discovery
January 19, 2022Research and Development
Engitix has announced the close of its $54m Series A financing, as well as a strategic collaboration, with Dompé farmaceutici …
MHRA license Jyseleca for treatment of ulcerative colitis
January 19, 2022Research and Development
Galapagos NV, the Belgian parent company of Galapagos Biotech Ltd, have announced that Jyseleca® (filgotinib 200mg tablets) has been granted …
UK launch of generic lenalidomide for myeloma
January 19, 2022Research and Development
Accord Healthcare have announced the UK launch of generic lenalidomide, available for the treatment of adult patients with multiple myeloma, …
SMC accepts first-line treatment for lung cancer
January 19, 2022Research and Development
The SMC has accepted AstraZeneca’s Tagrisso (osimertinib) for use as monotherapy for the first-line treatment of adult patients with locally …
Julie Beeso joins Envision Pharma Group as new Global Director
January 18, 2022Manufacturing and Production
Envision Pharma Group has appointed Julie Beeso as its Global Director, Professional Development and Engagement. Julie has worked for almost …
Mario Torchia appointed as new Vice President of Sales & Marketing at InSilicoTrials
January 18, 2022Manufacturing and Production
InSilicoTrials, a leader in simulation software solutions for healthcare, has announced Mario Torchia’s appointment. Torchia recently led the Sales Strategy …
Enhertu granted priority review in US for patients with HER2-positive metastatic breast cancer
January 18, 2022Manufacturing and Production
Enhertu, manufactured by AstraZeneca and Daiichi Sankyo, has been accepted for the treatment of adult patients in the US with …
SMC accept Enhertu for the treatment of HER2 positive metastatic breast cancer
January 18, 2022Manufacturing and Production
Daiichi Sankyo and AstraZeneca have announced that the SMC has accepted Enhertu® for use within NHS Scotland for the treatment …
Almirall and IRB Barcelona research for skin disease therapeutics discovery
January 18, 2022Manufacturing and Production
Almirall and IRB Barcelona (the Institute for Research in Biomedicine) have announced a research collaboration to identify the new oral …
Abbisko Therapeutics collaborates with Lilly to discover novel molecules
January 18, 2022Manufacturing and Production
Abbisko Therapeutics announced that it has entered into a partnership and exclusive licensing agreement with Eli Lilly and Company. This …
Neurimmune and Ono Pharmaceutical collaborate to research neurodegenerative diseases
January 17, 2022Sales and Marketing
Neurimmune AG has signed an expanded drug discovery collaboration agreement with Ono Pharmaceutical. The companies aim to focus on creating …
NICE draft guidance recommends new treatment for rare liver condition
January 17, 2022Sales and Marketing
On Friday 14 January, NICE published a final draft Highly Specialised Technologies guidance, recommending odevixibat in line with its marketing …
FDA places Alzheimer’s therapeutic IND Application on hold
January 17, 2022Sales and Marketing
The FDA has placed a hold on the Investigational New Drug (IND) application for DNL919, indicating they will provide an …
COVID-19 self-isolation cut to five full days in England
January 17, 2022Sales and Marketing
The minimum self-isolation period for people testing positive for COVID-19 in England has been cut from seven days to five …
AstraZeneca and Scorpion strike $1.5bn deal against hard-to-treat proteins
January 14, 2022Medical Communications
AstraZeneca and Scorpion have partnered to develop precision medicines against previously hard-to-target cancer proteins. The collaboration, valued at more than …
South Africa study shows J&J booster 85% effective against Omicron hospitalisation
January 14, 2022Medical Communications
The head of South Africa’s Medical Research Council (SAMRC) has revealed that a J&J booster shot is 85% effective in …
First melanoma test to offer reassurance of low risk of cancer spread
January 14, 2022Medical Communications
A new test reliably predicting the spread or return of the most deadly form of skin cancer has been developed …
WHO recommend two new COVID-19 treatments
January 14, 2022Medical Communications
WHO approved two new treatments for COVID-19 on 14 January, as Omicron cases continue globally, and WHO predicting half of …
Benevolent AI and AstraZeneca expand collaboration on heart failure and systemic lupus discovery
January 13, 2022Business Services
Leading clinical stage AI drug discovery company, Benevolent AI, has expanded its AI-driven drug discovery collaboration with AstraZeneca. This means …
Abivax receive EMA scientific advice support for ulcerative colitis trial
January 13, 2022Business Services
Abivax have received scientific advice from the EMA supporting advancing ABX464 into Phase III clinical testing, for the treatment of …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
